Keywords: cytheris, cyt107, enters, ph, i/iia, trial, sa

Cytheris' CYT107 enters Ph I/IIa trial

Article | 03 November 2008

Print This

Cytheris SA, a French clinical-stage biopharmaceutical company, has initiated a multicenter Phase I/IIa dose escalation study in Taiwan to ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in